0000313143-13-000131.txt : 20130726 0000313143-13-000131.hdr.sgml : 20130726 20130726175907 ACCESSION NUMBER: 0000313143-13-000131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130724 FILED AS OF DATE: 20130726 DATE AS OF CHANGE: 20130726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN PETER M CENTRAL INDEX KEY: 0001261832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 13990622 MAIL ADDRESS: STREET 1: HAEMONETICS CORP STREET 2: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184-9144 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-07-24 0 0000313143 HAEMONETICS CORP HAE 0001261832 ALLEN PETER M 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 President, Global Plasma Common Stock 26797 D Performance Shares 0.0 2013-07-24 2017-03-31 4 A 0 25000.0 0.0 A 2017-03-31 2017-12-31 Common Stock 25000 25000 D Non-Qualified Stock Option (right to buy) 13.0525 2005-05-05 2014-05-05 Common Stock 30000 30000 D Non-Qualified Stock Option (right to buy) 25.535 2008-10-24 2014-10-24 Common Stock 36426 36426 D Non-Qualified Stock Option (right to buy) 26.47 2010-10-27 2016-10-27 Common Stock 31340 31340 D Non-Qualified Stock Option (right to buy) 27.275 2009-10-22 2015-10-22 Common Stock 30494 30494 D Non-Qualified Stock Option (right to buy) 27.495 2011-10-27 2017-10-27 Common Stock 30776 30776 D Non-Qualified Stock Option (right to buy) 30.67 2012-10-25 2018-10-25 Common Stock 30740 30740 D Non-Qualified Stock Option (right to buy) 39.055 2013-10-24 2019-10-24 Common Stock 32192 32192 D Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d). Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. By: Alexander Steffan For: Peter Allen 2013-07-26